Markets
Basket of Politically Charged Stocks
(Scott Olson/Getty Images)

As America votes, a look back at how the market has judged the race

Nobody knows what’s going to happen, but here’s what the stock market has seen over the last year.

Matt Phillips

Let’s face it. Nobody’s really thinking about the stock market today, even though the S&P 500 is enjoying its best gains since mid-September.

Is that a clear sign that Trump is cruising to victory? After all, stocks that benefit from GOP policy positions, like private prison companies GEO Group and CoreCivic, are both enjoying a bump.

Or does it mean that Harris has the situation well in hand, as one might surmise upon seeing that large government contractors like Quanta Services and Granite Construction, which stand to gain from ongoing federal infrastructure spending, are sitting on healthy gains?

Market wizards at Goldman Sachs scoured the investable universe for such companies that could be reasonably categorized as potential beneficiaries of either Democratic or Republican policy goals. Then they lumped them into tradable baskets.

The chart of their respective performance this year, below, is a decent approximation of the thrills and spills that made this one of the most fascinating presidential races in recent memory.

As you can see, the Democratic-aligned stocks seemed to lose their advantage entirely after Biden’s disastrous debate performance, before pulling back into the lead after Biden dropped out and passed the baton to his vice president.

And like the polls, the gap between these two baskets has closed markedly over the last couple months.

But also like the polls, or the prediction markets, or whatever druidic necromancy you choose to foretell the future, nobody knows what’s going to happen. They just don’t.

That’s why the only choice we have is to sit back and wait for the votes to be counted. USA!

More Markets

See all Markets
markets

Spectrum owner Charter Communications is on pace for its worst day ever as broadband numbers and Q1 results disappoint

Cable and broadband company Charter Communications is on pace for its worst-ever trading day on Friday, as investors dump the stock following its Q1 results and forward guidance.

Charter, which owns Spectrum, reported adjusted earnings of $9.17 per share, below Wall Street estimates of $9.96 per share from analysts polled by FactSet. On the company’s earnings call, CFO Jessica Fischer appeared to lower its guidance for full-year revenue per user.

“It’ll be close either way in terms of whether we end up with net growth,” Fischer said.

The company lost 120,000 internet subscribers in the quarter, deeper than the expected 94,800 and double its loss from the same period last year. That news comes one day after Comcast’s earnings provided a bit of optimism for broadband as a category: the company reported Q1 losses of 65,000, significantly improving from 183,000 losses in the same quarter last year. Comcast is down more than 10%, on pace for its worst day since January 2025.

markets
Luke Kawa

Nvidia poised to snap longest run without a record close since the AI boom began

The stock price of the company responsible for the brains of the AI boom is finally showing some brawn again.

Nvidia, the world’s most valuable company, is poised to close at a record high for the first time since October 29, 2025, on Friday (if it ends above $207.04).

The AI chip trade is on fire, with the Philadelphia Semiconductor Index slated to deliver its 18th consecutive gain as Intel’s robust results and outlook juice the entire ecosystem. Hyperscalers report earnings next week, and their capex guidance can be thought of as the earnings guidance for Nvidia and other AI suppliers for the quarters to come.

This would end Nvidia’s longest stretch without a record close since the unofficial start of the AI boom (when the chip designer delivered blowout quarterly results in May 2023).

(Sorry if I jinx this!)

markets

Lilly slips after prescriptions for its weight-loss pill come in below expectations in second week

Eli Lilly fell on Friday after prescription data for its new weight-loss pill, Foundayo, showed that it’s having a significantly slower rollout than its top competitor.

The pill was prescribed about 3,700 times in its second week, according to IQVIA data cited by Deutsche Bank analysts, compared to the roughly 8,000 they were expecting. Novo Nordisk’s Wegovy pill, which came out in January, hit over 18,000 prescriptions in its second week.

The FDA approved Foundayo on April 1 and shipments began on April 9. Deutsche analysts noted that Lilly’s GLP-1 injections, which currently outsell Novo’s, also had a slower start.

Lilly fell more than 4% after the numbers were released. Novo Nordisk rose more than 5%.

Latest Stories

Sherwood Media, LLC produces fresh and unique perspectives on topical financial news and is a fully owned subsidiary of Robinhood Markets, Inc., and any views expressed here do not necessarily reflect the views of any other Robinhood affiliate, including Robinhood Markets, Inc., Robinhood Financial LLC, Robinhood Securities, LLC, Robinhood Crypto, LLC, Robinhood Derivatives, LLC, or Robinhood Money, LLC. Futures and event contracts are offered through Robinhood Derivatives, LLC.